Cargando…

Death risk among COVID-19 patients with diabetes mellitus

Deaths from COVID-19 are increasing in patients with comorbidities. One of the most common comorbidities is diabetes mellitus. The researchers wanted to see how having diabetes affected the mortality rate of COVID-19 participants. This investigation is a case control observational analytical study....

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlia, Dahlia, Artanti, Kurnia Dwi, Hargono, Arief, Martini, Santi, Nasr, Nayla Mohamed Gomaa, Li, Chung-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367039/
https://www.ncbi.nlm.nih.gov/pubmed/37497133
http://dx.doi.org/10.4081/jphia.2022.2399
_version_ 1785077302662529024
author Dahlia, Dahlia
Artanti, Kurnia Dwi
Hargono, Arief
Martini, Santi
Nasr, Nayla Mohamed Gomaa
Li, Chung-Yi
author_facet Dahlia, Dahlia
Artanti, Kurnia Dwi
Hargono, Arief
Martini, Santi
Nasr, Nayla Mohamed Gomaa
Li, Chung-Yi
author_sort Dahlia, Dahlia
collection PubMed
description Deaths from COVID-19 are increasing in patients with comorbidities. One of the most common comorbidities is diabetes mellitus. The researchers wanted to see how having diabetes affected the mortality rate of COVID-19 participants. This investigation is a case control observational analytical study. Different types of people, called “cases,” and “controls,” complete the research sample. Each group had 68 responders, for a grand total of 136. Medical records from COVID-19 patients treated at Airlangga University Hospital, Surabaya, between March 2020 and September 2021 serve as the study’s secondary data source. The purpose of this study’s data analysis is to calculate an odds ratio. Patients with COVID-19 with concomitant diabetes mellitus had an increased risk of death, and this risk increased with age, gender, and COVID-19 symptoms. In contrast, education, occupation, and laboratory results were not significantly related to mortality among COVID-19 individuals with concomitant diabetes mellitus (GDA status). The results of this study show that COVID-19 patients with concomitant diabetes mellitus are at a higher risk of death if they are over the age of 65, if they are male, and if they have severe symptoms.
format Online
Article
Text
id pubmed-10367039
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-103670392023-07-26 Death risk among COVID-19 patients with diabetes mellitus Dahlia, Dahlia Artanti, Kurnia Dwi Hargono, Arief Martini, Santi Nasr, Nayla Mohamed Gomaa Li, Chung-Yi J Public Health Afr Article Deaths from COVID-19 are increasing in patients with comorbidities. One of the most common comorbidities is diabetes mellitus. The researchers wanted to see how having diabetes affected the mortality rate of COVID-19 participants. This investigation is a case control observational analytical study. Different types of people, called “cases,” and “controls,” complete the research sample. Each group had 68 responders, for a grand total of 136. Medical records from COVID-19 patients treated at Airlangga University Hospital, Surabaya, between March 2020 and September 2021 serve as the study’s secondary data source. The purpose of this study’s data analysis is to calculate an odds ratio. Patients with COVID-19 with concomitant diabetes mellitus had an increased risk of death, and this risk increased with age, gender, and COVID-19 symptoms. In contrast, education, occupation, and laboratory results were not significantly related to mortality among COVID-19 individuals with concomitant diabetes mellitus (GDA status). The results of this study show that COVID-19 patients with concomitant diabetes mellitus are at a higher risk of death if they are over the age of 65, if they are male, and if they have severe symptoms. PAGEPress Publications, Pavia, Italy 2022-12-07 /pmc/articles/PMC10367039/ /pubmed/37497133 http://dx.doi.org/10.4081/jphia.2022.2399 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Dahlia, Dahlia
Artanti, Kurnia Dwi
Hargono, Arief
Martini, Santi
Nasr, Nayla Mohamed Gomaa
Li, Chung-Yi
Death risk among COVID-19 patients with diabetes mellitus
title Death risk among COVID-19 patients with diabetes mellitus
title_full Death risk among COVID-19 patients with diabetes mellitus
title_fullStr Death risk among COVID-19 patients with diabetes mellitus
title_full_unstemmed Death risk among COVID-19 patients with diabetes mellitus
title_short Death risk among COVID-19 patients with diabetes mellitus
title_sort death risk among covid-19 patients with diabetes mellitus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367039/
https://www.ncbi.nlm.nih.gov/pubmed/37497133
http://dx.doi.org/10.4081/jphia.2022.2399
work_keys_str_mv AT dahliadahlia deathriskamongcovid19patientswithdiabetesmellitus
AT artantikurniadwi deathriskamongcovid19patientswithdiabetesmellitus
AT hargonoarief deathriskamongcovid19patientswithdiabetesmellitus
AT martinisanti deathriskamongcovid19patientswithdiabetesmellitus
AT nasrnaylamohamedgomaa deathriskamongcovid19patientswithdiabetesmellitus
AT lichungyi deathriskamongcovid19patientswithdiabetesmellitus